BCM
MRNS

BluePath Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

BluePath Capital Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,730
Closed -$38.1K – 335
2023
Q3 		$38.1K Buy
+4,730
New +$38.1K 0.04% 209